Tolvaptan
| CAS No. | 150683-30-0 | Cat. No. | BCP22329 |
| Name | Tolvaptan | ||
| Synonyms | OPC-41061; OPC 41061; OPC41061; | ||
| Formula | C26H25ClN2O3 | M. Wt | 448.95 |
| Description | Tolvaptan is a selective, competitive vasopressin receptor 2 antagonist used to treat hyponatremia (low blood sodium levels) associated with congestive heart failure, cirrhosis, and the syndrome of inappropriate antidiuretic hormone (SIADH). Tolvaptan was approved by the U.S. Food and Drug Administration (FDA) on May 19, 2009. | ||
| Pathways | GPCR/G Protein | ||
| Targets | Vasopressin Receptor | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.